Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by bigwillyon Nov 13, 2016 9:31am

93 Views

Post# 25454248

RE:RE:RE:RE:RE:Upcoming Private Placement SP .085

I would like to ask where you think this is going? As the price has not went up yet the so called paid pump started on november 8th? Has the pump failed and now it is time to dump?

You throw out numbers abut volume which is absolutely true but you also go on about this paid promo...yes I see it on the otctoday website...But what are you saying, the pump is coming of the dump

Bullboard Posts

Barrick Gold employees detained in Mali amid ongoing dispute